HA
ELV icon

Harfst & Associates’s Elevance Health ELV Stock Holding History

Harfst & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-803
Closed -$349K – 105
2025
Q1 		$349K Sell
803
-110
-12% -$44.2K 0.08% 98
2024
Q4 		$337K Sell
913
-3,981
-81% -$1.67M 0.07% 75
2024
Q3 		$2.54M Buy
4,894
+341
+7% +$182K 0.57% 34
2024
Q2 		$2.47M Sell
4,553
-139
-3% -$73.5K 0.58% 28
2024
Q1 		$2.43M Sell
4,692
-19
-0.4% -$9.45K 0.58% 35
2023
Q4 		$2.22M Sell
4,711
-108
-2% -$49.9K 0.59% 37
2023
Q3 		$2.1M Buy
4,819
+19
+0.4% +$8.62K 0.59% 38
2023
Q2 		$2.13M Buy
4,800
+891
+23% +$411K 0.57% 40
2023
Q1 		$1.8M Sell
3,909
-20
-0.5% -$9.52K 0.52% 39
2022
Q4 		$2.02M Sell
3,929
-3
-0.1% -$1.52K 0.58% 29
2022
Q3 		$1.79M Buy
3,932
+320
+9% +$153K 0.54% 33
2022
Q2 		$1.74M Sell
3,612
-311
-8% -$154K 0.49% 28
2022
Q1 		$1.93M Buy
3,923
+337
+9% +$154K 0.45% 34
2021
Q4 		$1.66M Buy
3,586
+156
+5% +$65.6K 0.42% 44
2021
Q3 		$1.28M Sell
3,430
-67
-2% -$25.5K 0.35% 52
2021
Q2 		$1.33M Buy
3,497
+742
+27% +$284K 0.39% 49
2021
Q1 		$988K Buy
+2,755
New +$886K 0.3% 67

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harfst & Associates's ELV Position: Q2 2025 in Review

Harfst & Associates sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 803 shares — an estimated $349K sold.

Harfst & Associates first reported a position in ELV in Q1 2021 and held it in 17 quarters. The position peaked at $2.54M in Q3 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Harfst & Associates reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Harfst & Associates sold 803 Elevance Health shares in Q2 2025, an estimated $349K.
  • Harfst & Associates first reported a position in Elevance Health in Q1 2021 and held it in 17 quarters.
  • Harfst & Associates's Elevance Health position peaked at $2.54M in Q3 2024.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Harfst & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.